Cardiome -- CRME Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cardiome -- CRME

CRME 2.330

-2.1%

May 16 4:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: isthisit	11/5/2007 11:06:10 AM
	of 285

Can anyone in the know provide some insight on the upside this stock has following a positive panel vote? And for January 19th approval of the IV version? Also, when are the oral phase 2B results expected to be released and what effect will they have on the pps? Sorry, I am arriving a little late to this party and I am trying to wrap my head around the opportunity here? Basically, is this a momentum play leading up to the panel vote, or is the street fairly confident of approval and holding through the Jan 19 decision is the better play. Any thoughts appreciated. Thanks.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next